Fractional third and fourth dose of RTS,S/AS01 malaria candidate vaccine: A phase 2a controlled human malaria parasite infection and immunogenicity study

Jason A. Regules*, Susan B. Cicatelli, Jason W. Bennett, Kristopher M. Paolino, Patrick S. Twomey, James E. Moon, April K. Kathcart, Kevin D. Hauns, Jack L. Komisar, Aziz N. Qabar, Silas A. Davidson, Sheetij Dutta, Matthew E. Griffith, Charles D. Magee, Mariusz Wojnarski, Jeffrey R. Livezey, Adrian T. Kress, Paige E. Waterman, Erik Jongert, Ulrike Wille-ReeceWayne Volkmuth, Daniel Emerling, William H. Robinson, Marc Lievens, Danielle Morelle, Cynthia K. Lee, Bebi Yassin-Rajkumar, Richard Weltzin, Joe Cohen, Robert M. Paris, Norman C. Waters, Ashley J. Birkett, David C. Kaslow, W. Ripley Ballou, Christian F. Ockenhouse, Johan Vekemans

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

170 Scopus citations

Fingerprint

Dive into the research topics of 'Fractional third and fourth dose of RTS,S/AS01 malaria candidate vaccine: A phase 2a controlled human malaria parasite infection and immunogenicity study'. Together they form a unique fingerprint.

Medicine & Life Sciences